| payload |
{"created_at":"2026-04-10T20:20:53.146 {"created_at":"2026-04-10T20:20:53.146920+00:00","signal_type":"discovery_new_listings_delta","source":"discovery_ingestor","url":"https://www.nasdaq.com/articles/ibrx-stock-rises-7-strong-q1-2026-preliminary-results","value":{"fp":"3e118cd91f76fead","kind":"new_listings","published_at":"2026-04-10T18:54:00+00:00","source":"Nasdaq Stocks","summary":"ImmunityBio stock jumps 7% as Q1 2026 revenues surge 168% on strong Anktiva uptake, with expanding approvals and pipeline progress boosting momentum.","tickers":[],"title":"IBRX Stock Rises 7% on Strong Q1 2026 Preliminary Results","url":"https://www.nasdaq.com/articles/ibrx-stock-rises-7-strong-q1-2026-preliminary-results"}}... |